Treatment-Related Toxic Effects
pneumonitis, myelosuppression, fever
PNEUMONITIS
A total of 318 patients were enrolled in safety analysis. There was no significant difference in the incidence of toxic effects higher than grade 3. Grade 5 toxic effects occurred in 5 patients in each group, including 1 patient who experienced myelosuppression and 4 patients with pneumonitis in the RT group and 3 patients with pneumonitis and 2 patients with fever in the CRTCT group (